Cargando…
Linezolid for drug‐resistant pulmonary tuberculosis
BACKGROUND: Linezolid was recently re‐classified as a Group A drug by the World Health Organization (WHO) for treatment of multi‐drug resistant tuberculosis (MDR‐TB) and extensively drug‐resistant tuberculosis (XDR‐TB), suggesting that it should be included in the regimen for all patients unless con...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2019
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426281/ https://www.ncbi.nlm.nih.gov/pubmed/30893466 http://dx.doi.org/10.1002/14651858.CD012836.pub2 |